A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death. A1C remains the gold standard outcome predictor in diabetic dialysis patients

Diabetes Care

Volumn 35, Issue 7, 2012, Pages 1625-1628

  Kalantar Zadeh, Kamyar ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED PROTEIN; HEMOGLOBIN; HEMOGLOBIN A1C;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; DEATH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MORTALITY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTION; RELIABILITY; REVIEW; RISK FACTOR; SURVIVAL RATE; VALIDITY;

EID: 84862889112     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0483     Document Type: Review

References (32)

1. Kovesdy CP, Sharma K, Kalantar-Zadeh K. Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis 2008; 52:766-777
2. Kovesdy CP, Kalantar-Zadeh K. Enter the dragon: a Chinese epidemic of chronic kidney disease? Lancet 2012;379:783-785
3. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 2003;87: S24-S31 (Pubitemid 37315504)
4. Kalantar-Zadeh K, Derose SF, Nicholas S, Benner D, Sharma K, Kovesdy CP. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr 2009;19:33-37
5. Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial 2010;23:148-156
6. Wanner C, Krane V, März W, et al German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-248 (Pubitemid 41058323)
7. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008;73: 1062-1068 (Pubitemid 351543905)
8. Freedman BI, Andries L, Shihabi ZK, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol 2011;6:1635-1643
9. Mittman N, Desiraju B, Fazil I, et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney Int Suppl 2010;117:S41-S45
10. Lamb E, Venton TR, Cattell WR, Dawnay A. Serum glycated albumin and fructosamine in renal dialysis patients. Nephron 1993; 64:82-88 (Pubitemid 23117174)
11. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
12. Rubinow KB, Hirsch IB. Reexamining metrics for glucose control. JAMA 2011;305: 1132-1133
13. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509 (Pubitemid 44527322)
14. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis 2010;55:875-884
15. Wu MS, Yu CC, Yang CW, et al. Poor predialysis glycaemic control is a predictor of mortality in type II diabetic patients onmaintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-2110
16. Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-913 (Pubitemid 33636068)
17. McMurray SD, Johnson G, Davis S, McDougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis 2002;40:566-575 (Pubitemid 34971286)
18. Oomichi T, Emoto M, Tabata T, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-1500 (Pubitemid 44127570)
19. Feldt-Rasmussen B. Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney Int 2006;70: 1392-1394 (Pubitemid 44527307)
20. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007; 30:1049-1055 (Pubitemid 46684623)
21. Williams ME, Lacson E Jr, Teng M, Hakim RM, Lazarus JM. Extremes of glycemic control (HbA1C) increase hospitalization risk in diabetic hemodialysis patients in the USA. Am J Nephrol 2009;29:54-61
22. Williams ME, Lacson E Jr, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol 2010;5:1595-1601
23. Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 2011;6:1041-1048
24. Molnar MZ, Huang E, Hoshino J, et al. Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients. Diabetes Care 2011;34:2536-2541
25. Ricks J, Molnar MZ, Kovesdy CP, et al. Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes 2012;61:708-715
26. Drechsler C, Krane V, Ritz E, März W, Wanner C. Glycemic control and cardiovascular events in diabetic hemodialysis patients. Circulation 2009;120:2421-2428
27. Shurraw S, Hemmelgarn B, Lin M, et al Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med 2011;171:1920-1927
28. Mehrotra R, Duong U, Jiwakanon S, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011;58:418-428
29. Mehrotra R, Kalantar-Zadeh K, Adler S. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol 2011;6:1520-1522
30. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1C levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 2006;151:91
31. Tzamaloukas AH, Murata GH, Zager PG, Eisenberg B, Avasthi PS. The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. ASAIO J 1993;39:880-885 (Pubitemid 24005177)
32. Menon V, Greene T, Pereira AA, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005;16:3411-3417 (Pubitemid 46179345)